Search Results
You are looking at 1 - 2 of 2 items for
- Author or Editor: Luisito S. Pablo x
- Refine by Access: All Content x
Abstract
Objective—To compare the time to desaturation in healthy dogs that breathed oxygen or room air for 3 minutes before induction of anesthesia.
Animals—20 healthy dogs.
Procedures—Dogs were sedated with morphine and acepromazine maleate. Dogs received a 3-minute treatment of room air or oxygen (100 mL/kg/min) via face mask. Arterial blood samples were collected before and after treatment to determine PaCO 2, PaO 2, pH, and SaO 2; propofol (6 mg/kg, IV) was injected during a 7-second period, and the dogs were intubated. A lingual pulse oximeter probe was placed. Dogs remained disconnected from the breathing circuit until SpO 2 equaled 90% (desaturation point) and then connected and ventilated until the SpO 2 was ≥ 97%. Arterial blood samples were collected and SpO 2 was recorded every 30 seconds for 4 minutes and then every minute until the desaturation point. Times to first breath and the desaturation point were recorded. Data were collected at 0, 5, 30, 60, 90, 120, and 150 seconds.
Results—Mean ± SEM time to desaturation differed significantly between dogs treated with room air (69.6 ± 10.6 seconds) and oxygen (297.8 ± 42.0 seconds). Lowest mean PaO 2 and SaO 2 when dogs were breathing room air were 62 ± 6.3 mm Hg and 82.3 ± 4%, respectively, at 30 seconds.
Conclusions and Clinical Relevance—Preoxygenation for 3 minutes increased the time to desaturation in healthy dogs sedated with acepromazine and morphine in which anesthesia was induced with propofol.
Abstract
Objective—To compare preoperative administration of meloxicam and butorphanol to perioperative administration of butorphanol alone for control of postoperative signs of pain in dogs.
Animals—40 client-owned dogs scheduled for surgical repair of a cranial cruciate ligament rupture.
Procedure—Group-1 dogs received butorphanol (0.2 mg/kg, IV) and meloxicam (0.2 mg/kg, IV) just prior to surgery. Group-2 dogs received butorphanol just prior to surgery (0.2 mg/kg, IV) and at incision closure (0.1 mg/kg, IV). Pain assessment began 1 to 2 hours before surgery and from extubation until 24 hours after surgery by obtaining the following measurements: the visual analog scale (VAS) score, cumulative pain score (CPS), adjusted cumulative pain score, modified cumulative pain score, and the adjusted modified cumulative pain score (AMCPS). Serum cortisol concentration was measured between 12 to 24 and between 1 to 2 hours prior to surgery, and at 30 minutes, and 1, 2, 4, 8, 18, and 24 hours after extubation.
Results—No significant differences between treatment groups were observed in CPS or VAS score. At 8, 9, 10, and 11 hours after extubation, meloxicambutorphanol- treated dogs had a significantly lower AMCPS, compared with butorphanol-alone-treated dogs. Total serum cortisol concentration (area under the curve) during the measurement period was significantly lower in meloxicam-butorphanol-treated dogs, compared with butorphanol-alone treated dogs.
Conclusions and Clinical Relevance—Preoperative single dose administration of meloxicam-butorphanol is equivalent to or slightly better than the administration of 2 perioperative doses of butorphanol for the control of postoperative signs of pain in dogs. (Am J Vet Res 2002;63:1557–1563)
